Cited by 44Receptor Mechanisms and SignalingProtein Structure and DynamicsComputational Drug Discovery Methods

Improving homology modeling from low-sequence identity templates in Rosetta: A case study in GPCRs

Open access
Bender, Brian Joseph, Marlow, Brennica, Meiler, Jens·2020·PLoS Computational Biology

Published version of a preprint

Abstract

Abstract G-protein coupled receptors (GPCRs) represent a significant target class for pharmaceutical therapies. However, to date, only about 10% of druggable GPCRs have had their structures characterized at atomic resolution. Further, because of the flexibility of GPCRs, alternative conformations remain to be modeled, even after an experimental structure is available. Thus, computational modeling of GPCRs is a crucial component for understanding biological function and to aid development of new therapeutics. Previous single- and multi-template homology modeling protocols in Rosetta often generated non-native-like conformations of transmembrane α-helices and/or extracellular loops. Here we present a new Rosetta protocol for modeling GPCRs that is improved in two critical ways: Firstly, it uses a blended sequence- and structure-based alignment that now accounts for structure conservation in extracellular loops. Secondly, by merging multiple template structures into one comparative model, the best possible template for every region of a target GPCR can be used expanding the conformational space sampled in a meaningful way. This new method allows for accurate modeling of receptors using templates as low as 20% sequence identity, which accounts for nearly the entire druggable space of GPCRs. A model database of all non-odorant GPCRs is made available at www.rosettagpcr.org . Author Summary Structure-based drug discovery is among the new technologies driving the development of next generation therapeutics. Inherent to this process is the availability of a protein structure for virtual screening. The most heavily drugged protein family, G-protein coupled receptors (GPCRs), however suffers from a lack of experimental structures that could hinder drug development. Technical challenges prevent the determination of every protein structure, so we turn to computational modeling to predict the structures of the remaining proteins. Again, traditional techniques fail due to the high divergence of this family. Here, we build on available methods specifically for the challenge of modeling GPCRs. This new method outperforms other methods and allows for the ability to accurately model nearly 90% of the entire GPCR family. We therefore generate a model database of all GPCRs ( www.rosettagpcr.org ) for use in future drug development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pcbi.1007597

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RoseTTAFold has been evaluated since May 15th, 2021 on CAMEO; over the 69 medium and hard targets released during this time, it outperformed all other servers evaluated including Robetta, IntFold6-TS, BestSingleTemplate, and SWISS-MODEL.

    “RoseTTAFold has been evaluated since May 15th, 2021 on CAMEO; over the 69 medium and hard targets released during this time (May 15th, 2021 ~ June 19th, 2021), it outperformed all other servers evaluated in the experiment including Robetta (3), IntFold6-TS (8), BestSingleTemplate (9), and SWISS-MODEL (10) (Fig. 1C).”

    From Accurate prediction of protein structures and interactions using a 3-track network (2021) · cites this paper as [9]

    Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bender, B. J., Marlow, B., & Meiler, J.
Affiliations
Vanderbilt University (US)
Corresponding author
Meiler, Jens
Venue
PLoS Computational Biology
Published
2020-10-28
Volume
16
Issue
10
Pages
e1007597
ISSN
  • 1553-734X (ISSN-L)
  • 1553-7358
OpenAlex
W3097936550
Cited by
44
References
53
Citations by year
2026: 2 · 2025: 1 · 2024: 5 · 2023: 8 · 2022: 12 · 2021: 14 · 2020: 2
FWCI
3.00
Type
journal article
Language
en
Open access
Locations
  • PLoS Computational Biology (publishedVersion, public-domain)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, public-domain)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Vanderbilt University
  • Deutsche Forschungsgemeinschaft (421152132, SFB 1423)
  • National Institutes of Health (NIGMS R01)
  • National Heart, Lung, and Blood Institute (R01HL122010)
  • National Institute on Drug Abuse (DA046138, R01DA046138)
  • National Institute of General Medical Sciences (GM 07628, T32GM007628, R01GM080403, GM 080403, T32 GM07628, R01GM129261)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK058404)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
Keywords
homology modeling, G protein-coupled receptors, Rosetta, structure-based drug design, sequence-structure alignment, loop regions, model database
MeSH terms
Humans, Models, Molecular, Software, Sequence Alignment, Sequence Homology, Amino Acid, Computational Biology, Sequence Analysis, Protein, Receptors, G-Protein-Coupled

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review